Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium
Ruyi Huang,Yongyue Wei,Rayjean J Hung,Geoffrey Liu,Li Su,Ruyang Zhang,Xuchen Zong,Zuo-Feng Zhang,Hal Morgenstern,Irene Brüske,Joachim Heinrich,Yun-Chul Hong,Jin Hee Kim,Michele Cote,Angela Wenzlaff,Ann G Schwartz,Isabelle Stucker,John Mclaughlin,Michael W Marcus,Michael P A Davies,Triantafillos Liloglou,John K Field,Keitaro Matsuo,Matt Barnett,Mark Thornquist,Gary Goodman,Yi Wang,Size Chen,Ping Yang,Eric J Duell,Angeline S Andrew,Philip Lazarus,Joshua Muscat,Penella Woll,Janet Horsman,M Dawn Teare,Anath Flugelman,Gad Rennert,Yan Zhang,Hermann Brenner,Christa Stegmaier,Erik H F M van der Heijden,Katja Aben,Lambertus Kiemeney,Juan Barros-Dios,Monica Pérez-Ríos,Alberto Ruano-Ravina,Neil E Caporaso,Pier Alberto Bertazzi,Maria Teresa Landi,Juncheng Dai,Hongbing Hongbing Shen,Guillermo Fernandez-Tardon,Marta Rodriguez-Suarez,Adonina Tardon,David C Christiani
DOI: https://doi.org/10.1016/j.ebiom.2015.09.031
IF: 11.205
EBioMedicine
Abstract:Background: The high relapse and mortality rate of small-cell lung cancer (SCLC) fuels the need for epidemiologic study to aid in its prevention. Methods: We included 24 studies from the ILCCO collaboration. Random-effects panel logistic regression and cubic spline regression were used to estimate the effects of smoking behaviors on SCLC risk and explore their non-linearity. Further, we explored whether the risk of smoking on SCLC was mediated through COPD. Findings: Significant dose-response relationships of SCLC risk were observed for all quantitative smoking variables. Smoking pack-years were associated with a sharper increase of SCLC risk for pack-years ranged 0 to approximately 50. The former smokers with longer cessation showed a 43%quit_for_5-9 years to 89%quit_for_≥ 20 years declined SCLC risk vs. subjects who had quit smoking < 5 years. Compared with non-COPD subjects, smoking behaviors showed a significantly higher effect on SCLC risk among COPD subjects, and further, COPD patients showed a 1.86-fold higher risk of SCLC. Furthermore, smoking behaviors on SCLC risk were significantly mediated through COPD which accounted for 0.70% to 7.55% of total effects. Interpretation: This is the largest pooling study that provides improved understanding of smoking on SCLC, and further demonstrates a causal pathway through COPD that warrants further experimental study.